The prognostic/ predictive value of the systematic inflammatory response in patients receiving immunotherapy for non-small cell lung cancer: a systematic review and meta-analysis

The prognostic/ predictive value of the systematic inflammatory response in patients receiving immunotherapy for non-small cell lung cancer: a systematic review and meta-analysis

Abstract Background The second most common malignancy after breast cancer is lung cancer (LC). Small cell lung cancer accounts for 15%, while non-small lung cancer (NSCLC) accounts for 85% of cases. Immunotherapy has improved treatment outcomes in NSCLC. However, the role of systemic inflammation-ba...

Full description

Saved in:
Bibliographic Details
Main Authors: Randa Saeed, Stephen McSorley, Almudena Cascales, Donald C. McMillan
Format: Article
Language:English
Published: BMC 2025-06-01
Series:BMC Cancer
Subjects:
Systemic Inflammation Biomarkers
Overall Survival
Advanced Non-Small Cell Lung Cancers
Immunotherapy
Systematic Review
Meta-Analysis
Online Access:https://doi.org/10.1186/s12885-025-13822-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12885-025-13822-9

Similar Items